Dunn 2021 Arterioscler Thromb Vasc Biol: Difference between revisions

From Bioblast
(Created page with "{{Publication |title=Dunn LL, Kong SMY, Tumanov S, Chen W, Cantley J, Ayer A, Maghzal GJ, Midwinter RG, Chan KH, Ng MKC, Stocker R (2021) Hmox1 (heme oxygenase-1) protects ag...")
ย 
No edit summary
ย 
(One intermediate revision by one other user not shown)
Line 12: Line 12:
|keywords=Amputation, Cardiovascular disease, Heme oxygenase-1, Metabolism, Peripheral vascular diseases
|keywords=Amputation, Cardiovascular disease, Heme oxygenase-1, Metabolism, Peripheral vascular diseases
|editor=[[Reiswig R]]
|editor=[[Reiswig R]]
|mipnetlab=AU Sydney Stocker R, AU Sydney Kong S
}}
}}
{{Labeling
{{Labeling

Latest revision as of 10:15, 12 January 2022

Publications in the MiPMap
Dunn LL, Kong SMY, Tumanov S, Chen W, Cantley J, Ayer A, Maghzal GJ, Midwinter RG, Chan KH, Ng MKC, Stocker R (2021) Hmox1 (heme oxygenase-1) protects against ischemia-mediated injury via stabilization of HIF-1ฮฑ (hypoxia-inducible factor-1ฮฑ). Arterioscler Thromb Vasc Biol 41:317-30.

ยป PMID: 33207934 Open Access

Dunn Louise L, Kong Stephanie M Y, Tumanov Sergey, Chen Weiyu, Cantley James, Ayer Anita, Maghzal Ghassan J, Midwinter Robyn G, Chan Kim H, Ng Martin K C, Stocker Roland (2021) Arterioscler Thromb Vasc Biol

Abstract: Hmox1 (heme oxygenase-1) is a stress-induced enzyme that catalyzes the degradation of heme to carbon monoxide, iron, and biliverdin. Induction of Hmox1 and its products protect against cardiovascular disease, including ischemic injury. Hmox1 is also a downstream target of the transcription factor HIF-1ฮฑ (hypoxia-inducible factor-1ฮฑ), a key regulator of the body's response to hypoxia. However, the mechanisms by which Hmox1 confers protection against ischemia-mediated injury remain to be fully understood.

Hmox1 deficient (Hmox1-/-) mice had impaired blood flow recovery with severe tissue necrosis and autoamputation following unilateral hindlimb ischemia. Autoamputation preceded the return of blood flow, and bone marrow transfer from littermate wild-type mice failed to prevent tissue injury and autoamputation. In wild-type mice, ischemia-induced expression of Hmox1 in skeletal muscle occurred before stabilization of HIF-1ฮฑ. Moreover, HIF-1ฮฑ stabilization and glucose utilization were impaired in Hmox1-/- mice compared with wild-type mice. Experiments exposing dermal fibroblasts to hypoxia (1% O2) recapitulated these key findings. Metabolomics analyses indicated a failure of Hmox1-/- mice to adapt cellular energy reprogramming in response to ischemia. Prolyl-4-hydroxylase inhibition stabilized HIF-1ฮฑ in Hmox1-/- fibroblasts and ischemic skeletal muscle, decreased tissue necrosis and autoamputation, and restored cellular metabolism to that of wild-type mice. Mechanistic studies showed that carbon monoxide stabilized HIF-1ฮฑ in Hmox1-/- fibroblasts in response to hypoxia.

Our findings suggest that Hmox1 acts both downstream and upstream of HIF-1ฮฑ, and that stabilization of HIF-1ฮฑ contributes to Hmox1's protection against ischemic injury independent of neovascularization. โ€ข Keywords: Amputation, Cardiovascular disease, Heme oxygenase-1, Metabolism, Peripheral vascular diseases โ€ข Bioblast editor: Reiswig R โ€ข O2k-Network Lab: AU Sydney Stocker R, AU Sydney Kong S


Labels: MiParea: Respiration, Genetic knockout;overexpression 

Stress:Hypoxia  Organism: Mouse  Tissue;cell: Skeletal muscle  Preparation: Permeabilized tissue 


Coupling state: LEAK, OXPHOS, ET  Pathway: F, N, S, NS, ROX  HRR: Oxygraph-2k 

2021-08 

Cookies help us deliver our services. By using our services, you agree to our use of cookies.